Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps with early hair regrowth in people with alopecia areata.

Oral tofacitinib successfully treated total body hair loss in one patient.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Finasteride can cause itching, burning, and other side effects that may not go away after treatment.

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

Indinavir and ritonavir therapy can cause reversible hair loss.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

A kidney transplant patient got a fungal infection from her dogs, but treatment improved her condition and hair grew back.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Excessive sun protection might contribute to frontal fibrosing alopecia.

COVID-19 may cause increased and quicker hair loss compared to other infections.

Finasteride improves hair loss in women with hyperandrogenism.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

A woman with severe hair loss regrew mostly white hair after treatment.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.

The dietary supplement helped increase hair growth in women with hair loss.

Hair loss in a child was an early sign of Crohn's disease.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Fluphenazine and iloprost can induce hair growth.

Hydroxychloroquine may help some hair disorders, but results vary.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.

Valproate can cause hair loss and changes in hair appearance, but may help regrow hair when applied topically.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.